Barbigerone, a natural isoflavone, induces apoptosis in murine lung-cancer cells via the mitochondrial apoptotic pathway

Cellular Physiology and Biochemistry

Volumn 24, Issue 1-2, 2009, Pages 95-104

  Li, Zheng Guang ^a   Zhao, Ying Lan ^a   Wu, Xiaohua ^a   Ye, Hao Yu ^a   Peng, Aihua ^a   Cao, Zhi Xing ^a   Mao, Yong Qiu ^a   Zheng, Yu Zhu ^a   Jiang, Pei Du ^a   Zhao, Xia ^b   Chen, Li Juan ^a,b   Wei, Yu Quan ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Barbigerone; Lung cancer; Mitochondrial apoptotic pathway

Indexed keywords

BARBIGERONE; CASPASE 3; CASPASE 9; CYTOCHROME C; ISOFLAVONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; LUNG CANCER; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

MURINAE;

EID: 67650429988     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227817     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world lung cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Steiner C, Arnould S, Scalbert A, Manach C: Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nut 2008;99 E Suppl 1:ES78-108.
4. Wu AH, Koh WP, Wang R, Lee HP, Yu MC: Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer 2008;99:196-200.
5. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC: Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 2008;68:2024-2032.
6. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH: Molecular Evidence for Increased Antitumor Activity of Gemcitabine by Genistein In vitro and In vivo Using an Orthotopic Model of Pancreatic Cancer. Cancer Res 2005;65:9064-9072.
7. Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG: Down-regulation of apurinic/apyrimidinic endonuclease 1/ redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res 2007;67:2141-2149.
8. Villain C: Barbigerone, a new pyranoisoflavone from seeds of tephrosia barbigera. Phytochemistry 1980;19:988-989.
9. Wangensteen H, Alamgir M, Rajia S, Samuelsen AB, Malterud KE: Rotenoids and isoflavones from Satcolobus globosus. Planta Med 2005;71:754-758.
10. Yenesew A, Midiwo JO and Waterma PG: Rotenoids, isoflavones and chalcones from the stem bark of Millettia Usaramensis subspecies usaramensis. Phytochemistry 1998;47:295-300.
11. Dagne E, Bekele A: C-prenylated isoflavones from millettia ferrugznea. Phytochemistry 1990;29:2679-2682.
12. Wangensteen H, Miron A, Alamgir M, Rajia S, Samuelsen AB, Malterud KE: Antioxidant and 15-lipoxygenase inhibitory activity of rotenoids, isoflavones and phenolic glycosides from Sarcolobus globosus. Fitoterapia 2006;77:290-295.
13. Yenesew A, Derese S, Midiwo JO, Oketch-Rabah HA, Lisgarten J, Palmer R, Heydenreich M, Peter MG, Akala H, Wangui J, Liyala P, Waters NC: Antiplasmodial activities and X-ray crystal structures of rotenoids from Millettia usaramensis subspecies usaramensis. Phytochemistry 2003;64:773-779.
14. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A: Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 2006;66:4410-4418.
15. Herr I, Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 2001;98:2603-2614.
16. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM: Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 2001;20:1063-1075.
17. Liu M, Pelling JC, Ju J, Chu E, Brash DE: Antioxidant action via p53-mediated apoptosis. Cancer Res 1998;58:1723-1729.
18. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y: Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res 1994;204:898-904.
19. Dowsett M, Archer C, Assersohn L, Gregory RK, Ellis PA, Salter J, Chang J, Mainwaring P, Boeddinghaus I, Johnston SR, Powles TJ, Smith IE: Clinical studies of apoptosis and proliferation in breast cancer. Endocr Relat Cancer 1999;6:25-28.
20. Chun KH, Kosmeder II JW, Sun SH, Pezzuto JM, Lotan R, Hong WK, Lee HY: Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells. J Natl Cancer Inst 2003;95:293-302.
21. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC: Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation. J Natl Cancer Inst 2005;97:1746-59.
22. Nunez G, Benedict MA, Hu Y, Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene 1998;17:3237-3245.
23. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490.
24. Li Y, Upadhyay S, Bhuiyan M, Sarkar F: Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999;18:3166-3172.
25. Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T, Wakabayashi K: Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn J Clin Oncol 1998;28:360-363.
26. Rice L, Samedi VG, Medrano TA, Sweeney CA, Baker HV, Stenstrom A, Furman J, Shiverick KT: Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate 2002;52:201-212.
27. Henry-Mowatt J, Dive C, Martinou JC, James D: Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 2004;23:2850-2860.
28. Ferreira CG, Epping M, Kruyt FA, Giaccone G: Apoptosis: Target of Cancer Therapy. Clin Cancer Res 2002;8:2024-2034.
29. Green DR, Amarante-Mendes GP: The point-of-no-return: mitochondria, caspases and the commitment to cell death. Results Probl Cell Differ 1998;24:45-61.
30. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 1998; 281: 1305 - 1308.
31. Adams JM, Cory S: The bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
32. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312.
33. Gross A, McDonnell JM, Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911.
34. Ghribi O, Herman MM, Spaulding NK, Savory J: Lithium inhibits aluminuminduced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem 2002;82:137-145.
35. Amundson SA, Myers T, Scudiero D, Kitada S, Reed JC, Fornace AJ Jr: An informatics approach indentifying markers of chemosensitivity in human cancer cells. Cancer Res 2000;60:6101-6110.
36. Wang S, DeGroff VL, Clinton SK: Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 2003;133:2367-76.
37. Knowles LM, Zigrossi DA, Tauber RA, Hightower C, Milner JA: Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 2000;38:116-22.
38. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R: Genisteininduced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997;51:193-200.
39. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A: Genistein arrests cell cycle progression at G2-M. Cancer Res 1993; 53: 1328 - 1331.
40. Dave B, Eason RR, Till SR, Geng Y, Velarde MC, Badger TM, Simmen RC: The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 2005;26:1793-1803.
41. Chen JT, Fong YC, Li TM, Liu JF, Hsu CW, Chang CS, Tang CH: DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells. Eur J Pharmacol 2008;597:19-26.
42. Crowell JA, Steele VE: AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment. J Natl Cancer Inst 2003;95(4):252-253.
43. Crowell JA, Steele VE, Fay JR: Targeting the AKT protein kinase for cancer chemoprevention. Mol Cancer Ther 2007;6:2139-2148.